{
    "2021-05-26": [
        [
            {
                "time": "",
                "original_text": "海南子公司获单采血浆许可 博雅生物有望“挤进”血制品龙头行列",
                "features": {
                    "keywords": [
                        "海南子公司",
                        "单采血浆许可",
                        "博雅生物",
                        "血制品",
                        "龙头企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}